Medical device company settles with SEC and DoJ for FCPA violations
On 29 March 2019 the U.S. Securities and Exchange Commission (SEC) announced a settlement with Fresenius Medical Care AG & Co KGaA (FMC) for Foreign Corrupt Practices Act (FCPA) violations. FMC has agreed to pay more that $230 million to the SEC and to the U.S. Department of Justice (DoJ) for numerous violations that include bribery, falsifying documents and insufficient internal accounting controls. FMC, based in Bad Homburg, Germany, is a medical device company that provides products and services for individuals with chronic kidney failure.
Please click here to read the SEC Order.